Translate 
Abstract
The growing interest in the health benefits of probiotics has led to increased demand for products containing these microorganisms, highlighting two key challenges: their survival in diverse food matrices and their survival within the gastrointestinal tract. Thus, this study aimed to optimize the formulation of microencapsulated Limosilactobacillus fermentum K73 with high oleic palm oil (HOPO) and whey, using double emulsification (W/O/W) and spray drying to enhance probiotic protection. Double emulsification was performed using high-shear homogenization at 11,000 rpm, dispersing the probiotic in oil as the first phase and then in whey as the aqueous phase. Spray drying was carried out at inlet and outlet temperatures 200°C and 90°C, respectively. The response variables were the zeta potential of the emulsions, bacterial cycle changes after drying and bile exposure, and powder moisture content. The optimal emulsion had a zeta potential of -23 mV, with bacterial cycle changes of 0.32 log CFU/mL after drying and 1.52 log CFU/mL after bile exposure, and a moisture content of 4.12%. Two synbiotics were prepared by adding a postbiotic from L. fermentum fermentation and a prebiotic (2’-fucosyllactose). In vitro digestion following the INFOGEST protocol showed synbiotics reaching the intestinal phase at 4.9–6.02 log CFU/mL. In conclusion, double emulsification combined with spray drying produced microencapsulates that survived gastrointestinal conditions at adequate concentrations, enabling their potential use for colonic delivery to evaluate effects on host health.Graphical
Highlights
Nowadays, numerous bioactive compounds have been investigated as potential modulators and precursors of gut microbiota health
This experimental design permitted the co-encapsulation of the probiotic L. fermentum K73 with high oleic palm oil in a double emulsion, which was sealed by spray drying
It has been demonstrated that double emulsification enhances the viability of probiotics encapsulated in them, as evidenced by studies conducted by Abbasi and colleagues and Lisboa Silva and colleagues [40, 41]
Summary
Numerous bioactive compounds have been investigated as potential modulators and precursors of gut microbiota health. Whey-based microcapsules have been shown to release Lactobacillus rhamnosus in a controlled manner within the intestinal environment, with survival rates ranging from 5.1 to 5.7 log CFU/mL under low pH conditions [7]. Lipid-based microcapsules, such as solid lipid particles or emulsions, have been shown to provide superior protection against the gastrointestinal tract conditions when compared to other carriers [8, 9] In this context, high-oleic palm oil could help to ensure the viability of probiotics as they traverse the stomach and small intestine, as encapsulates of this oil that contains alpha and beta-carotenes, tocopherols and tocotrienols allows them to arrive to the intestine and be bioaccessible preserving their beneficial effects [10, 11]
Sign-in/Register to view highlights & summary 
Paper version not known (
Free)
Published Version
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
